Kansas Receives $812,000 in National Drug Settlement

By  | 

Kansas has received more than $812,000 as part of a settlement with a pharmaceutical company accused of delaying the availability of a generic version of a drug.

The money was awarded after a lawsuit was filed in December 2001 by all 50 states, the District of Columbia and Puerto Rico against Bristol-Myers Squibb, Watson Pharma and Danbury Pharmacal.

The lawsuit claimed the companies violated antitrust laws in preventing generic versions of the BuSpar anxiety drug from reaching the market.

The attorney general's office said today that $655,000 from the settlement will go to the state's Medicaid program, with the remainder funds going the state general fund.